Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +13.25%
#3 Bitway Bitway +11.68%
#4 Glidr Glidr +9.69%
#5 Meteora Meteora +9.51%
#6 OPENLOOT OPENLOOT +8.29%
#7 Unit Pump Unit Pump +8.17%
#8 Pump.fun Pump.fun +8.17%
#9 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.80%
#10 eCash eCash +7.48%
Coin of the day
PulseChain PulseChain
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Helyezés a részvények között #28041
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Részvényárfolyam
$0.55
Utolsó szinkronizálás: 2025-02-11
Piaci kapitalizáció
$28.90M
Változás (1 nap)
0.00%
Változás (1 év)
0.00%
Ország
US
Kereskedés Marinus Pharmaceuticals, Inc. (MRNS)

Kategória

Healthcare
Marinus Pharmaceuticals, Inc. (MRNS) részvényárfolyamának története
Legmagasabb napi záróár: $0.55 ekkor: 2025-02-01

Legalacsonyabb napi záróár: $8.00 ekkor: 2014-07-01
Marinus Pharmaceuticals, Inc. részvényárfolyamának története 2014 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2025 81.15%
2024 -86.72%
2023 124.80%
2022 -63.10%
2021 -18.02%
2020 95.30%
2019 -53.99%
2018 -51.67%
2017 728.84%
2016 -86.53%
2015 -16.46%
2014 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.91 -13.46%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 5.84%
CH